Aerosol particle generation from solution-based pressurized metered dose inhalers: a technical overview of parameters that influence respiratory deposition

References

• Munro SJM, Cripps AL. Metered Dose Inhalers. In: Swarbrick J, ed. Encyclopedia of Pharmaceutical Technology. 3rd ed. New York: Informa Healthercare; 2006:2269–2285
   Google Scholar
• Sanchis J, Corrigan C, Levy ML, Viejo JL. Inhaler devices from theory to practice. Respiratory medicine 2013;107:495–502
   Google Scholar
• Terzano C. Pressurized metered dose inhalers and add-on devices. Pulm Pharmacol Ther 2001;14:351–366
   PubMed Web of Science ®Google Scholar
• Smyth HDC. Propellant-driven metered-dose inhalers for pulmonary drug delivery. Expert Opin Drug deliv 2005;2:53–74
   PubMedGoogle Scholar
• McDonald KJ, Martin GP. Transition to CFC-free metered dose inhalers – into the new millennium. Int J Pharm 2000;201:89–107
   PubMed Web of Science ®Google Scholar
• Newman SP. Principles of metered-dose inhaler design. Resp Care 2005;50:1177–1190
   PubMedGoogle Scholar
• Bell J, Newman S. The rejuvenated pressurised metered dose inhaler. Expert Opin Drug Deliv 2007;4:215–234
   PubMed Web of Science ®Google Scholar
• Dalby RN, Byron PR. Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions. Pharm Res 1988;5:36–39
   PubMed Web of Science ®Google Scholar
• Gonda I. Development of a systematic theory of suspension inhalation aerosols. I. A framework to study the effects of aggregation on the aerodynamic behavior of drug particles. Int J Pharm 1985;27:99–116
   Web of Science ®Google Scholar
• Byron PR. Pulmonary targeting with aerosols. Pharm Tech 1987;11:42–56
   Google Scholar
• Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 2010;392:1–19
   PubMed Web of Science ®Google Scholar
• Leach CL. Inhalation aspects of therapeutic aerosols. Toxicol Pathol 2007;35:23–26
   PubMed Web of Science ®Google Scholar
• Howarth P. Why particle size should affect clinical response to inhaled therapy. J Aerosol Med 2001;14:27–34
   PubMedGoogle Scholar
• Feddah MR, Brown KF, Gipps EM, Davies NM. In vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates. J Pharm Pharm Sci 2000;3:318–324
   PubMed Web of Science ®Google Scholar
• Leach C, Colice GL, Luskin A. Particle size of inhaled corticosteroids: does it matter? J Allergy Clin Immunol 2009;124:S88–S93
   PubMed Web of Science ®Google Scholar
• Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Brit J Clin Pharmacol 2003;56:600–612
   PubMed Web of Science ®Google Scholar
• Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:44–51
   PubMed Web of Science ®Google Scholar
• Lewis D, Ganderton D, Meakin B, Brambilla G. Theory and practice with solution systems. Resp Drug Deliv 2004;IX:109–115
   Google Scholar
• Smith IJ, Parry-Billings M. The inhalers of the future? A review of dry powder devices on the market today. Pulm Pharm Ther 2003;16:79–95
   PubMed Web of Science ®Google Scholar
• Hindle M, Byron PR. Dose emissions from marketed dry powder inhalers. Int J Pharm 1995;116:169–177
   Web of Science ®Google Scholar
• Chapman K, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest 1993;104:1332–1337
   PubMed Web of Science ®Google Scholar
• Hanania N, Wittman R, Kesten S, Chapman K. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994;105:111–116
   PubMed Web of Science ®Google Scholar
• Keller M. Innovations and perspectives of metered dose inhalers in pulmonary drug delivery. Int J Pharm 1999;186:81–90
   PubMed Web of Science ®Google Scholar
• Smyth HDC. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv Drug deliv Rev 2003;55:807–828
   PubMed Web of Science ®Google Scholar
• Vervaet C, Byron PR. Drug–surfactant–propellant interactions in HFA-formulations. Int J Pharm 1999;186:13–30
   PubMed Web of Science ®Google Scholar
• June D. Achieving the change: challenges and successes in the formulation of CFC-free MDIs. Eur Resp Rev 1997;7:32–34
   Google Scholar
• Leach C, Davidson P, Boudreau R. Improved airway targeting with the CFC-free HFA–beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Resp J 1998;12:1346–1353
   PubMed Web of Science ®Google Scholar
• Brambilla G, Ganderton D, Garzia R, et al. Modulation of aerosol clouds produced by pressurised inhalation aerosols. Int J Pharm 1999;186:53–61
   PubMed Web of Science ®Google Scholar
• Haynes WM, Lide DR, Bruno TJ. CRC handbook of chemistry and physics, 93rd ed. CRC Press, Boca Raton; 2012
   Google Scholar
• Tzou TZ, Pachuta RR, Coy RB, Schultz RK. Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability. J Pharm Sci 1997;86:1352–1357
   PubMed Web of Science ®Google Scholar
• Cope M, Bautista-Parra F. The degradation of salbutamol in ethanolic solutions. J Pharm Biomed Anal 2010;52:210–215
   PubMed Web of Science ®Google Scholar
• Stein SW, Myrdal PB. The relative influence of atomization and evaporation on metered dose inhaler drug delivery efficiency. Aerosol Sci Technol 2006;40:335–347
   Web of Science ®Google Scholar
• Williams III RO, Hu C. Moisture uptake and its influence on pressurized metered-dose inhalers. Pharm Dev Technol 2000;5:153–162
   PubMed Web of Science ®Google Scholar
• Blondino FE, Byron PR. Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants. Drug Dev Ind Pharm 1998;24:935–945
   PubMed Web of Science ®Google Scholar
• Williams G. Moisture transport into CFC-free MDIs. Resp Drug Deliv VI 1998;1:471–474
   Google Scholar
• Gelotte KM, Shadeed DJ. Water solubility in metered-dose inhaler median containing different propellants. Pharm Sci 1998;1:210
   Google Scholar
• Robson P, Selvam P, da Rocha SRP. Microscopic and thermodynamic properties of the HFA134a-water interface: atomistic computer simulations and tensiometry under pressure. Langmuir 2006;22:8826–8830
   PubMed Web of Science ®Google Scholar
• Williams III RO, Hu C. Influence of water on the solubility of two steroid drugs in hydrofluoroalkane (HFA) propellants. Drug Dev Ind Pharm 2001;27:71–79
   PubMed Web of Science ®Google Scholar
• Lewis DA. Intrinsic particle size distribution: a new metric to guide the design of HFA solution pMDIs. RRD Eur 2013 2013;1:175–184
   Google Scholar
• Zhu B, Traini D, Chan H-K, Young P. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers. Drug Dev Ind Pharm 2013;39:1625–1637
   PubMed Web of Science ®Google Scholar
• Zhu B, Traini D, Lewis DA, Young P. The solid-state and morphological characteristics of particles generated from solution-based metered dose inhalers: influence of ethanol concentration and intrinsic drug properties. Colloid Surface A: Physicochem Eng Aspect 2014;443:345–355
   Web of Science ®Google Scholar
• Shemirani FM, Hoe S, Lewis D, et al. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs. J Aerosol Med Pulm Drug Deliv 2013;26:215–222
   PubMed Web of Science ®Google Scholar
• Martin AR, Kwok DY, Finlay WH. Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments. J Aerosol Med: J Int Soc Aerosols Med 2005;18:218–224
   PubMedGoogle Scholar
• Stein SW, Myrdal PB. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. J Pharm Sci 2004;93:2158–2175
   PubMed Web of Science ®Google Scholar
• Clarke JG, Wicks SR, Farr SJ. Surfactant mediated effects in pressurized metered dose inhalers formulated as suspensions. I. Drug/surfactant interactions in a model propellant system. Int J Pharm 1993;93:221–231
   Web of Science ®Google Scholar
• Rance R. Particle size distribution measurement of hair sprays using an image-splitting particle size analyser. J Soc Cosmet Chem 1972;23:197–208
   Google Scholar
• Rance R. Studies of the factors controlling the action of hair sprays II. The adhesion of hair spray resins to hair fibers. J Soc Cosmet chem 1974;25:297–306
   Google Scholar
• Dunbar C. Atomization mechanism of the pressurized metered dose inhaler. Particul Sci Technol 1997;15:253–271
   Web of Science ®Google Scholar
• Clark AR. Metered atomisation for respiratory drug delivery [dissertation]. UK: Loughborough University; 1991
   Google Scholar
• Dunbar C, Watkins A, Miller J. An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. J Aerosol Med 1997;10:351–368
   PubMedGoogle Scholar
• Clark AR. MDIs: physics of aerosol formation. J Aerosol Med 1996;9:19–26
   PubMedGoogle Scholar
• Domnick J, Durst F. Measurement of bubble size, velocity and concentration in flashing flow behind a sudden constriction. Int J Multiphas Flow 1995;21:1047–1062
   Web of Science ®Google Scholar
• Sher E, Elata C. Spray formation from pressure cans by flashing. Ind Eng Chem Proc Design Dev 1977;16:237–242
   Web of Science ®Google Scholar
• Smyth HDC. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers. AAPS PharmSciTech 2003;4:76–86
   Google Scholar
• Wigley G, Versteeg H, Hodson D, ed. Near-orifice PDA measurements and atomisation mechanism of a pharmaceutical pressurised metered dose inhaler. Zaragoza: ILASS-Europe; 2002
   Google Scholar
• Lewis D. Intrinsic particle size distribution: a new metric to guide the design of HFA solution pMDIs. RRD Eur 2013 2013;1:175–184
   Google Scholar
• Zhu B, Traini D, Chan H-K, Young PM. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers. Drug Dev Ind Pharm 2013;39:1625–1637
   PubMed Web of Science ®Google Scholar
• Gelfand B. Droplet breakup phenomena in flows with velocity lag. Prog Energy Combust Sci 1996;22:201–265
   Web of Science ®Google Scholar
• Shraiber A, Podvysotsky A, Dubrovsky V. Deformation and breakup of drops by aerodynamic forces. Atomization Spray 1996;6:667–692
   Web of Science ®Google Scholar
• Ju D, Shrimpton J, Hearn A. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers. Int J Pharm 2010;391:221–229
   PubMed Web of Science ®Google Scholar
• Crosland BM, Johnson MR, Matida EA. Characterization of the spray velocities from a pressurized metered-dose inhaler. J Aerosol Med Pulm Drug Deliv 2009;22:85–98
   PubMed Web of Science ®Google Scholar
• Kleinstreuer C, Shi H, Zhang Z. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology. J Aerosol Med 2007;20:294–309
   PubMedGoogle Scholar
• Shi H, Kleinstreuer C. Simulation and analysis of high-speed droplet spray dynamics. J Fluid Eng 2007;129:621–633
   Web of Science ®Google Scholar
• Tanner F. Liquid jet atomization and droplet breakup modeling of non-evaporating diesel fuel sprays. 1997; SAE Technical Paper. doi:10.4271/970050
   Google Scholar
• Faeth G, Hsiang LP, Wu PK. Structure and breakup properties of sprays. Int J Multiphase Flow 1995;21:99–127
   Web of Science ®Google Scholar
• Wierzba A, Takayama K. Experimental investigation of the aerodynamic breakup of liquid drops. AIAA J 1988;26:1329–1335
   Google Scholar
• Faeth GM. Current status of droplet and liquid combustion. Prog Energ Combus Sci 1977;3:191–224
   Web of Science ®Google Scholar
• Davies C. Evaporation of airborne droplets. Fundam Aerosol Sci 1978;1:135–164
   Google Scholar
• Hinds WC. Aerosol technology: properties, behavior, and measurement of airborne particles. New York: John Wiley and Sons; 1982
   Google Scholar
• Martin AR, Kwok DY, Finlay WH. Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments. J Aerosol Med 2005;18:218–224
   PubMedGoogle Scholar
• Gonda I. A semi-empirical model of aerosol deposition in the human respiratory tract for mouth inhalation. J Pharm Pharmacol 1981;33:692–696
   PubMed Web of Science ®Google Scholar
• Byron PR. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J Pharm Sci 1986;75:433–438
   PubMed Web of Science ®Google Scholar
• Melani AS, Zanchetta D, Barbato N, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol 2004;93:439–446
   PubMed Web of Science ®Google Scholar
• Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 2007;6:67–74
   PubMed Web of Science ®Google Scholar
• Dalby RN, Phillips EM, Byron PR. Determination of drug solubility in aerosol propellants. Pharm Res 1991;8:1206–1209
   PubMed Web of Science ®Google Scholar
• Williams III RO, Rogers TL, Liu J. Study of solubility of steroids in hydrofluoroalkane propellants. Drug Dev Ind Pharm 1999;25:1227–1234
   PubMed Web of Science ®Google Scholar
• Traini D, Young PM, Price R, Rogueda P. A novel apparatus for the determination of solubility in pressurized metered dose inhalers. Drug Dev Ind Pharm 2006;32:1159–1163
   PubMed Web of Science ®Google Scholar
• Gupta A, Myrdal PB. Novel method for the determination of solubility in aerosol propellants. J Pharm Sci 2004;93:2411–2419
   PubMed Web of Science ®Google Scholar
• Mogalian E, Kuehl PJ, Myrdal PB. New analytical techniques to facilitate preformulation screening in propellant systems. Int J Pharm 2007;340:223–229
   PubMed Web of Science ®Google Scholar
• Gupta A, Myrdal PB. A comparison of two methods to determine the solubility of compounds in aerosol propellants. Int J Pharm 2005;292:201–209
   PubMed Web of Science ®Google Scholar
• Dickinson P, Seville P, McHale H, et al. An investigation of the solubility of various compounds in the hydrofluoroalkane propellants and possible model liquid propellants. J Aerosol Med 2000;13:179–186
   PubMedGoogle Scholar
• Fedors RF. A method for estimating both the solubility parameters and molar volumes of liquids. Polym Eng Sci 1974;14:147–154
   Web of Science ®Google Scholar
• Hoye JA, Myrdal PB. Measurement and correlation of solute solubility in HFA-134a/ethanol systems. Int J Pharm 2008;362:184–188
   PubMed Web of Science ®Google Scholar
• Scatchard G. Equilibria in non-electrolyte solutions in relation to the vapor pressures and densities of the components. Chem Rev 1931;8:321–333
   Google Scholar
• Hildebrand JH. Solubility. III. Relative values of internal pressures and their practical application. J Am Chem Soc 1919;41:1067–1080
   Google Scholar
• Gupta A, Stein SW, Myrdal PB. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers. J Aerosol Med 2003;16:167–174
   PubMedGoogle Scholar
• Conti DS, Grashik J, Yang L, et al. Solvation in hydrofluoroalkanes: how can ethanol help? J Pharm Pharmacol 2012;64:1236–1244
   PubMed Web of Science ®Google Scholar
• Rogueda PG. HPFP, a model propellant for pMDIs. Drug Dev Ind Pharm 2003;29:39–49
   PubMed Web of Science ®Google Scholar
• Paul A, Griffiths PC, James R, et al. Explaining the phase behaviour of the pharmaceutically relevant polymers poly (ethylene glycol) and poly (vinyl pyrrolidone) in semi-fluorinated liquids. J Pharm Pharmacol 2005;57:973–980
   PubMed Web of Science ®Google Scholar
• Ganderton D, Lewis D, Davies R, et al. The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler. Resp Med 2003;97:S4–S9
   Web of Science ®Google Scholar
• Mitchell JP, Nagel MW. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J Aerosol Med 2003;16:341–377
   PubMedGoogle Scholar
• Myrdal PB, Stein SW, Mogalian E, et al. Comparison of the TSI model 3306 impactor inlet with the Andersen cascade impactor: solution metered dose inhalers. Drug Dev Ind Pharm 2004;30:859–868
   PubMed Web of Science ®Google Scholar
• Stein SW, Gabrio BJ, Oberreit D, et al. An evaluation of mass-weighted size distribution measurements with the model 3320 aerodynamic particle sizer. Aerosol Sci Technol 2002;36:845–854
   Web of Science ®Google Scholar
• Liu X, Doub WH, Guo C. Evaluation of metered dose inhaler spray velocities using phase doppler anemometry (PDA). Int J Pharm 2011;423:235–239
   PubMedGoogle Scholar
• Stein SW. Estimating the number of droplets and drug particles emitted from MDIs. AAPS PharmSciTech 2008;9:112–115
   PubMed Web of Science ®Google Scholar
• Dunbar C, Watkins AP, Miller J. Theoretical investigation of the spray from a pressurized metered-dose inhaler. Atomization Spray 1997;7:417–436
   Web of Science ®Google Scholar
• Hochrainer D, Hölz H, Kreher C, et al. Comparison of the aerosol velocity and spray duration of Respimat® Soft Mist™ inhaler and pressurized metered dose inhalers. J Aerosol Med 2005;18:273–282
   PubMedGoogle Scholar
• Gabrio BJ, Stein SW, Velasquez DJ. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm 1999;186:3–12
   PubMed Web of Science ®Google Scholar
• Smyth H, Hickey A, Brace G, et al. Spray pattern analysis for metered dose inhalers I: orifice size, particle size, and droplet motion correlations. Drug Dev Ind Pharm 2006;32:1033–1041
   PubMed Web of Science ®Google Scholar
• Kontny M, Destefano G, Jager P, et al. Issues surrounding MDI formulation development with non-CFC propellants. J Aerosol Med 1991;4:181–187
   PubMedGoogle Scholar
• Smyth H, Brace G, Barbour T, et al. Spray pattern analysis for metered dose inhalers: effect of actuator design. Pharm Res 2006;23:1591–1596
   PubMed Web of Science ®Google Scholar
• Dunbar CA. An experimental and the theoretical investigation of the spray issued from a pressurized metered-dose inhlaer [dissertation]. University of Manchester; 1996
   Google Scholar
• Brambilla G, Church T, Lewis D, Meakin B. Plume temperature emitted from metered dose inhalers. Int J Pharm 2011;405:9–15
   PubMedGoogle Scholar
• Stein S, Gabrio B, Myrdal P. The influence of vapor pressure on the size of atomized MDI droplets. Resp Drug Deliv Eur 2005;1:151–155
   Google Scholar
• Dunbar C, Mitchell J. Analysis of cascade impactor mass distributions. J Aerosol Med 2005;18:439–451
   PubMedGoogle Scholar
• Ganderton D, Lewis D, Davies R, et al. Modulite®: a means of designing the aerosols generated by pressurized metered dose inhalers. Resp Med 2002;96:S3–S8
   PubMed Web of Science ®Google Scholar
• Woodcock A, Acerbi D, Poli G. Modulite® technology: pharmacodynamic and pharmacokinetic implications. Resp Med 2002;96:S9–S15
   PubMed Web of Science ®Google Scholar
• Acerbi D, Brambilla G, Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using modulite technology. Pulm Pharmacol Ther 2007;20:290–297
   PubMed Web of Science ®Google Scholar
• Williams III RO, Liu J. Influence of formulation additives on the vapor pressure of hydrofluoroalkane propellants. Int J Pharm 1998;166:99–103
   Google Scholar
• Williams RO, Repka M, Liu J. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler. Drug Dev Ind Phar 1998;24:763–770
   PubMed Web of Science ®Google Scholar
• Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size. J Pharm Sci 1969;58:484–486
   PubMed Web of Science ®Google Scholar
• Warren SJ, Farr SJ. Formulation of solution metered dose inhalers and comparison with aerosols emitted from conventional suspension systems. Int J Pharm 1995;124:195–203
   Web of Science ®Google Scholar
• Ju D, Shrimpton J, Bowdrey M, Hearn A. Effect of expansion chamber geometry on atomization and spray dispersion characters of a flashing mixture containing inerts. Part II: high speed imaging measurements. Int J Pharm 2012b;432:32–41
   PubMedGoogle Scholar
• Ju D, Shrimpton J, Bowdrey M, Hearn A. Effect of expansion chamber geometry on atomization and spray dispersion characters of a flashing mixture containing inerts. Part I: numerical predictions and dual laser measurements. Int J Pharm 2012a;432:23–31
   PubMedGoogle Scholar
• Berry J, Heimbecher S, Hart JL, Sequeira J. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler. Drug Dev Ind Pharm 2003;29:865–876
   PubMed Web of Science ®Google Scholar
• Newman SP, Newhouse MT. Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects. J Aerosol Med 1996;9:55–70
   PubMedGoogle Scholar
• Terzano C. Metered dose inhalers and spacer devices. Eur Rev Med Pharmacol Sci 1999;3:159–170
   PubMedGoogle Scholar
• Nikander K, Nicholls C, Denyer J, Pritchard J. The evolution of spacers and valved holding chambers. J Aerosol Med Pulm Drug Deliv 2014;27:S-4–S-23
   Web of Science ®Google Scholar
• Bennett WD, Brown JS, Zeman KL, et al. Targeting delivery of aerosols to different lung regions. J Aerosol Med 2002;15:179–188
   PubMedGoogle Scholar
• Asmus MJ, Coowanitwong I, Kwon SH, et al. In vitro performance of two common valved holding chambers with a chlorofluorocarbon-free beclomethasone metered dose inhaler. Pharmacother: J Hum Pharmacol Drug Ther 2003;23:1538–1544
   Google Scholar
• Byron PR. Dosing reproducibility from experimental albuterol suspension metered-dose inhalers. Pharma Res 1994;11:580–584
   Google Scholar